Neurological diseases(e.g., Myasthenia gravis, Guillain-Barré syndrome, Chronic inflammatory demyelinating polyneuropathy, Multiple sclerosis)
Features of IMMUSORBA TR-350 (L)
Therapeutic plasmapheresis by removing pathogenic substances (anti-acetylcholine receptor antibodies and immune complexes) from patient's plasma by selective adsorption.
No need for the replacement of plasma, minimizing the risk of infection with hepatitis, AIDS, etc.
Applicable to patients with protein allergy